Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Werner-Wasik

Showing results (141-150 of 159) with videos related to

Pageof 16
Sort By:
Neurosurgery|April 5, 2018
Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported OutcomesWilliam A Hall, Stephanie L Pugh, Jeffrey S Wefel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 7, 2020
Low Nonrelapse Mortality after HLA-Matched Related 2-Step Hematopoietic Stem Cell Transplantation Using Cyclophosphamide for Graft-versus-Host Disease Prophylaxis and the Potential Impact of Non- Cyclophosphamide-Exposed T Cells on OutcomesDolores Grosso, Matthew Carabasi, Joanne Filicko-O'Hara, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2025
Comprehensive Molecular Analysis in NRG Oncology/RTOG 9813: A Phase III Study of Radiation and Temozolomide Versus Radiation and BCNU/CCNU in Anaplastic AstrocytomaJessica L Fleming, Stephanie L Pugh, Susan M Chang, et al.
Neuro-Oncology|February 21, 2018
Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group databaseDeborah T Blumenthal, Minhee Won, Minesh P Mehta, et al.
Neuro-Oncology|November 11, 2017
A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913Prakash Chinnaiyan, Minhee Won, Patrick Y Wen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019
Estimation of the α/β ratio of non-small cell lung cancer treated with stereotactic body radiotherapyRainer J Klement, Jan-Jakob Sonke, Michael Allgäuer, et al.
JAMA Oncology|July 29, 2021
Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non-Small Cell Lung Cancer: The NRG-LU001 Phase 2 Randomized Clinical TrialHeath Skinner, Chen Hu, Theodoros Tsakiridis, et al.
Practical Radiation Oncology|April 19, 2023
Consensus Quality Measures and Dose Constraints for Lung Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and ASTRO Expert PanelLindsay L Puckett, Mohammad Titi, Ksenija Kujundzic, et al.
International Journal of Radiation Oncology, Biology, Physics|March 20, 2020
Correlating Dose Variables with Local Tumor Control in Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Modeling Study on 1500 Individual TreatmentsRainer J Klement, Jan-Jakob Sonke, Michael Allgäuer, et al.
Neuro-Oncology|December 21, 2016
Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813Susan Chang, Peixin Zhang, J Gregory Cairncross, et al.
Pageof 16

Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
Neurosurgery|April 5, 2018
Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported OutcomesWilliam A Hall, Stephanie L Pugh, Jeffrey S Wefel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 7, 2020
Low Nonrelapse Mortality after HLA-Matched Related 2-Step Hematopoietic Stem Cell Transplantation Using Cyclophosphamide for Graft-versus-Host Disease Prophylaxis and the Potential Impact of Non- Cyclophosphamide-Exposed T Cells on OutcomesDolores Grosso, Matthew Carabasi, Joanne Filicko-O'Hara, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2025
Comprehensive Molecular Analysis in NRG Oncology/RTOG 9813: A Phase III Study of Radiation and Temozolomide Versus Radiation and BCNU/CCNU in Anaplastic AstrocytomaJessica L Fleming, Stephanie L Pugh, Susan M Chang, et al.
Neuro-Oncology|February 21, 2018
Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group databaseDeborah T Blumenthal, Minhee Won, Minesh P Mehta, et al.
Neuro-Oncology|November 11, 2017
A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913Prakash Chinnaiyan, Minhee Won, Patrick Y Wen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019
Estimation of the α/β ratio of non-small cell lung cancer treated with stereotactic body radiotherapyRainer J Klement, Jan-Jakob Sonke, Michael Allgäuer, et al.
JAMA Oncology|July 29, 2021
Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non-Small Cell Lung Cancer: The NRG-LU001 Phase 2 Randomized Clinical TrialHeath Skinner, Chen Hu, Theodoros Tsakiridis, et al.
Practical Radiation Oncology|April 19, 2023
Consensus Quality Measures and Dose Constraints for Lung Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and ASTRO Expert PanelLindsay L Puckett, Mohammad Titi, Ksenija Kujundzic, et al.
International Journal of Radiation Oncology, Biology, Physics|March 20, 2020
Correlating Dose Variables with Local Tumor Control in Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Modeling Study on 1500 Individual TreatmentsRainer J Klement, Jan-Jakob Sonke, Michael Allgäuer, et al.
Neuro-Oncology|December 21, 2016
Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813Susan Chang, Peixin Zhang, J Gregory Cairncross, et al.
Pageof 16